{
  "pmcid": "4357072",
  "config": {
    "model": "gemini",
    "strategy": "zero-shot"
  },
  "usage": {
    "input": 4330,
    "output": 640
  },
  "raw_text": "```json\n{\n  \"extractions\": [\n    {\n      \"outcome\": \"improvement in symptom scores\",\n      \"intervention\": \"topical pimecrolimus cream 1%\",\n      \"comparator\": \"triamcinolone acetonide oral paste 0.1%\",\n      \"outcome_type\": \"continuous\",\n      \"intervention_events\": null,\n      \"intervention_group_size\": 15,\n      \"comparator_events\": null,\n      \"comparator_group_size\": 15,\n      \"intervention_mean\": 58.3,\n      \"intervention_standard_deviation\": 23.4,\n      \"comparator_mean\": 44.0,\n      \"comparator_standard_deviation\": 24.1\n    },\n    {\n      \"outcome\": \"reduction in burning sensation\",\n      \"intervention\": \"topical pimecrolimus cream 1%\",\n      \"comparator\": \"triamcinolone acetonide oral paste 0.1%\",\n      \"outcome_type\": \"continuous\",\n      \"intervention_events\": null,\n      \"intervention_group_size\": 15,\n      \"comparator_events\": null,\n      \"comparator_group_size\": 15,\n      \"intervention_mean\": 58.3,\n      \"intervention_standard_deviation\": 23.4,\n      \"comparator_mean\": 44.0,\n      \"comparator_standard_deviation\": 24.1\n    },\n    {\n      \"outcome\": \"reduction in erythematous area\",\n      \"intervention\": \"topical pimecrolimus cream 1%\",\n      \"comparator\": \"triamcinolone acetonide oral paste 0.1%\",\n      \"outcome_type\": \"binary\",\n      \"intervention_events\": 14,\n      \"intervention_group_size\": 15,\n      \"comparator_events\": 10,\n      \"comparator_group_size\": 15,\n      \"intervention_mean\": null,\n      \"intervention_standard_deviation\": null,\n      \"comparator_mean\": null,\n      \"comparator_standard_deviation\": null\n    },\n    {\n      \"outcome\": \"reappearance of erythematous areas after 2 months posttreatment\",\n      \"intervention\": \"pimecrolimus\",\n      \"comparator\": \"triamcinolone acetate\",\n      \"outcome_type\": \"binary\",\n      \"intervention_events\": 1,\n      \"intervention_group_size\": 15,\n      \"comparator_events\": 5,\n      \"comparator_group_size\": 15,\n      \"intervention_mean\": null,\n      \"intervention_standard_deviation\": null,\n      \"comparator_mean\": null,\n      \"comparator_standard_deviation\": null\n    }\n  ]\n}\n```",
  "extraction": [
    {
      "outcome": "improvement in symptom scores",
      "intervention": "topical pimecrolimus cream 1%",
      "comparator": "triamcinolone acetonide oral paste 0.1%",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 15,
      "comparator_events": null,
      "comparator_group_size": 15,
      "intervention_mean": 58.3,
      "intervention_standard_deviation": 23.4,
      "comparator_mean": 44.0,
      "comparator_standard_deviation": 24.1,
      "pmcid": "4357072"
    },
    {
      "outcome": "reduction in burning sensation",
      "intervention": "topical pimecrolimus cream 1%",
      "comparator": "triamcinolone acetonide oral paste 0.1%",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 15,
      "comparator_events": null,
      "comparator_group_size": 15,
      "intervention_mean": 58.3,
      "intervention_standard_deviation": 23.4,
      "comparator_mean": 44.0,
      "comparator_standard_deviation": 24.1,
      "pmcid": "4357072"
    },
    {
      "outcome": "reduction in erythematous area",
      "intervention": "topical pimecrolimus cream 1%",
      "comparator": "triamcinolone acetonide oral paste 0.1%",
      "outcome_type": "binary",
      "intervention_events": 14,
      "intervention_group_size": 15,
      "comparator_events": 10,
      "comparator_group_size": 15,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "4357072"
    },
    {
      "outcome": "reappearance of erythematous areas after 2 months posttreatment",
      "intervention": "pimecrolimus",
      "comparator": "triamcinolone acetate",
      "outcome_type": "binary",
      "intervention_events": 1,
      "intervention_group_size": 15,
      "comparator_events": 5,
      "comparator_group_size": 15,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "4357072"
    }
  ]
}